BBO-10203

N/A

Report date: 2025/12/12 16:59:21
NME

Base Information

Drug NameBBO-10203
Drug Alias NameBBO-10203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitorsV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRasPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsHyperglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBridgebio Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesBridgebio Pharma Inc
Inactive CompaniesN/A
Active IndicationsHyperglycemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A